Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 31;17(7):5108-5121.
doi: 10.21037/jtd-2025-430. Epub 2025 Jul 28.

Pregnancy in patients with pulmonary hypertension: a systematic review and meta-analysis with meta-regression

Mahmoud El Iskandarani  1 , Reshma Golamari  2 , Branco G M Bettinotti  2 , Elias Akiki  2 , Daniela Urina Jassir  2 , Tarec K Elajami  2 , Francine K Welty  3 , Esteban Escolar  2 , Christos G Mihos  2
Affiliations

Pregnancy in patients with pulmonary hypertension: a systematic review and meta-analysis with meta-regression

Mahmoud El Iskandarani et al. J Thorac Dis. .

Abstract

Background: Pregnancy in patients with significant pulmonary hypertension (PH) is a contraindication due to high maternal and fetal mortality. However, recent data shows that an increasing number of women with PH are successfully carrying pregnancies to term, likely because of advancements in multidisciplinary care and treatment. This systematic review and meta-analysis aims to evaluate recent outcomes and identify risk factors associated with morbidity and mortality in this high-risk group.

Methods: An unrestricted search was conducted across MEDLINE, EMBASE, and Cochrane databases for studies on outcomes in pregnant patients with PH from inception until May 30, 2024. For one-group analyses, event rates and 95% confidence interval (CI) were calculated using a random-effects model. Meta-regression was performed with Comprehensive Meta-Analysis version 4, employing covariates in logistic regression models. For two-group comparisons, odd ratios (ORs) and 95% CIs were calculated using Review Manager version 5.4 utilizing a random-effects model.

Results: Fifty-one studies involving 4,583 pregnant patients with PH were included. The maternal mortality rate was 7.6% (95% CI: 5.8-9.9%). Most deaths (93%) occurred in the postpartum period. Severe PH was associated with a significantly higher rate of maternal mortality compared to mild/moderate PH with OR 5.57 (95% CI: 3.12-9.94). Higher systolic pulmonary artery pressure (sPAP) was associated with a higher mortality rate with a regression coefficient of 0.96. Similarly, the presence of Eisenmenger syndrome (ES) was linked to a higher mortality rate with a regression coefficient of 1. Severe PH was also associated with higher rates of abortion (OR =3.64, 95% CI: 2.61-5.09), prematurity (OR =2.52, 95% CI: 1.66-3.81), and small gestational age (OR =3.96, 95% CI: 2.96-5.29) compared with mild/moderate PH.

Conclusions: Although the outcomes of pregnant patients with PH continue to improve, severe PH continues to be associated with a high mortality rate, abortion rate, prematurity, and small gestational age. Our findings support the existing consensus against pregnancy in severe PH and emphasize the need for thorough, individualized discussions about risks for patients with mild/moderate PH.

Keywords: Pulmonary hypertension (PH); maternal mortality; pregnancy; systolic pulmonary artery hypertension.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2025-430/coif). C.G.M. serves as an unpaid editorial board member of Journal of Thoracic Disease from February 2025 to January 2027. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Flow diagram of record allocation.
Figure 2
Figure 2
Maternal mortality rate in severe PH vs. mild/moderate PH (16,55). CI, confidence interval; M-H, Mantel-Haenszel; PH, pulmonary hypertension.
See this image and copyright information in PMC

References

    1. Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2023;61:2200879. 10.1183/13993003.00879-2022 - DOI - PubMed
    1. Silversides CK, Grewal J, Mason J, et al. Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study. J Am Coll Cardiol 2018;71:2419-30. 10.1016/j.jacc.2018.02.076 - DOI - PubMed
    1. Canobbio MM, Warnes CA, Aboulhosn J, et al. Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2017;135:e50-87. 10.1161/CIR.0000000000000458 - DOI - PubMed
    1. Lima FV, Yang J, Xu J, et al. National Trends and In-Hospital Outcomes in Pregnant Women With Heart Disease in the United States. Am J Cardiol 2017;119:1694-700. 10.1016/j.amjcard.2017.02.003 - DOI - PubMed
    1. Thomas E, Yang J, Xu J, et al. Pulmonary Hypertension and Pregnancy Outcomes: Insights From the National Inpatient Sample. J Am Heart Assoc 2017;6:e006144. 10.1161/JAHA.117.006144 - DOI - PMC - PubMed